Hemp Pharma Amro Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth -8395.41%
- Ebitda -6129.09%
- Net Worth -737.74%
- Total Assets 9122.53%
About Hemp Pharma Amro
Hemp Pharma Amro Private Limited (HPAPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 August 2014 and has a history of Ten years and six months. Its registered office is in Gurugram, Haryana, India.
The Corporate was formerly known as Amro Organic Hemp Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rohit Sharma, Chandra Shah, and Desh Sharma serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U15122HR2014PTC052999
- Company No.
052999
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 2014
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Hemp Pharma Amro?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Sharma  | Director | 07-Aug-2014 | Current |
| Chandra Shah | Director | 04-Jul-2018 | Current |
| Desh Sharma | Director | 07-Aug-2014 | Current |
Financial Performance of Hemp Pharma Amro.
Hemp Pharma Amro Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 8395.41% decrease in profit. The company's net worth observed a substantial decline by a decrease of 737.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hemp Pharma Amro?
In 2019, Hemp Pharma Amro had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Canindica Private LimitedRohit Sharma is a mutual person
Bulls Quant Amro Private LimitedRohit Sharma is a mutual person
- All India Tapovan Institute Of Pharma
Rohit Sharma and Desh Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hemp Pharma Amro?
Hemp Pharma Amro has a workforce of 5 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hemp Pharma Amro, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemp Pharma Amro's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.